SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
FY18 showed solid gains in all segments, up +5.7% YoY, as antimicrobial devices take the lead.
Q418 US Spine market remains fairly flat, rounding out a stable but unremarkable FY18. SmartTRAK’s Finan...
SmartTRAK Subscribers: See only news for the Markets, Modules and Segments and TYPES of content that you...
Pricing pressure and tough comps slow year end growth SmartTRAK reports that pricing pressure and a slow...
Following the last fall's Advanced Wound Care meeting, SmartTRAK's Susan Paquette, VP Wound, reported on...
Revenues down again, owing to intense competitive pricing pressures Pricing pressure continued to negati...
Typically, Q4 is a rebound quarter for Total Joints, but SmartTRAK reports that the Q418 US market exper...
01With the upcoming orthopedic conference season upon us, we thought it would be interesting to take a l...
.png)
SmartTRAK highlights trends shaping the Extremities Market It’s no surprise orthopedic companies continu...
Doug Devens, SmartTRAK's Senior Analyst, Biosurgery wrote a fascinating article titled "Growth Amid Deba...
Login